MDGL compared with CELC: revenue, margins and what each company keeps, and the suppliers and customers both name

MDGLMadrigal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

CELCCelcuity Inc.

Mkt capRevenueRevenue

Compare

MDGLMadrigal Pharmaceuticals, Inc.

CELCCelcuity Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MDGL 8

PFEPfizersupplier

—Gregory Pharmaceutical Holdings, Inc. (d/b/a UPM Pharmaceuticals)unlistedsupplier

—Rocheunlistedsupplier

—Cowenunlistedsupplier

4 more · MDGL chain ›

Shared 0

No disclosed counterparties: CELC.

Only CELC 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

MDGLMadrigal Pharmaceuticals, Inc.

432.96▲+0.60%· post 432.96

Mkt cap$9.9BRevenue$364MQ2 FY26Revenue$958MFY25

CELCCelcuity Inc.

67.31▼−2.63%· post 67.31

ClosedNov 2 '26

Mkt cap$3.3BRevenue—Revenue—

Compare

ClosedNov 2 '26

MDGLMadrigal Pharmaceuticals, Inc.

CELCCelcuity Inc.

432.96▲+0.60%post 432.96

Price

67.31▼−2.63%post 67.31

$9.9B

Mkt cap

$3.3B

Q2 FY26$364M

Revenue

—

FY25$958M

Revenue

—

MDGL432.96▲+0.60%vsCELC67.31▼−2.63%ClosedNov 2 '26